Trial intelligence / Profile preview

Safety of Lacosamide Monotherapy Conversion in Japanese Adults

NCT02124564Phase 3Completed

Sponsor
UCB
Start
Apr 2014
Primary completion
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of lacosamide in focal onset seizure, sponsored by UCB. Started Apr 2014; status: completed.

02

Drugs

lacosamide
03

Conditions

focal onset seizure

Beyond the preview

Go deeper on NCT02124564.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02124564.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call